HEALTHCARE AI
“ We are very proud to have introduced the market to teledermatology ”
ITAI HAYUT CEO AND CO-FOUNDER ,
SCOPIO LABS
“ By breaking these barriers for imaging and combining with clinical-grade AI , one can start to see the potential of viewing millions of cells in the sample and the unique deep analysis that AI can support , unlocking a world of new diagnostic opportunities for drastically earlier detection and diagnosis of bloodrelated cancers , anaemia , and infections . This provides the clinician with a new , revolutionary approach to first-line laboratory testing ,” says Hayut .
Following FDA clearance of its smaller , 3-slide device at the end of 2020 , Scopio Labs has since obtained FDA clearance for its high-throughput 30-slide device , expanding its capabilities now to larger labs , networks and medical facilities .
“ Scopio is currently developing applications that leverage the groundbreaking Full-Field imaging technology , going beyond the limitations of the human eye and manual microscopic examination ,” Hayut says . “ Scopio will enable lab professionals to analyse not hundreds , but tens of thousands and even millions of cells at a scale and depth that has never been done before , transforming the future of blood-related disease detection and diagnosis .”
healthcare-digital . com 85